Subscribe To
Seeking high dividends? 3 fairly valued/undervalued high dividend yield stocks for your portfolio
High dividend yield companies are valuable assets for your portfolio, since they are a great way to gen...
November 4, 2023, 3:00 pm
Warren buffett's berkshire hathaway dumps billions worth of stocks for 4th consecutive quarter
Berkshire Hathaway reports a 41% growth in operating income for Q3 2023. Warren Buffett slows down share buybacks despite strong earnings and record c...
November 4, 2023, 1:37 pm
India's economic rise demands investor attention
By Angus Shillington, Deputy portfolio Manager, Emerging Markets Equity and John Patrick Lee, CFA, Prod...
November 4, 2023, 11:29 am
The often overlooked and misunderstood bond buy
By Eric Fine, portfolio Manager, Emerging Markets Fixed Income Rising rates and emerging risks in devel...
November 4, 2023, 11:29 am
A fleeting opportunity to upgrade your dividend portfolio quality
Dividend investors have a chance to upgrade their portfolios with high-quality dividend growth stocks a...
November 4, 2023, 8:45 am
Ecora resources: the green transition causes a short-term pain, but the prospects are good
Ecora Resources is transitioning to become a "green" royalty and streaming company, focusing on copper, cobalt, and nickel. The company's cornerstone ...
November 4, 2023, 3:48 am
Vig: a bet on the u.s. economy
Vanguard Dividend Appreciation ETF is a good option for new investors or those seeking safety and stability in a high-quality ETF. VIG has a blended <...
November 4, 2023, 2:58 am
Fibra macquarie: heavily exposed to nearshoring trend
FIBRA Macquarie is a real estate investment trust in Mexico focused on industrial, commercial, and office properties. Mexico's strategic location and ...
November 4, 2023, 1:50 am
Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at
RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...
November 3, 2023, 11:30 pm
Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at
RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...
November 3, 2023, 11:30 pm
Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at
RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...
November 3, 2023, 11:30 pm
Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at
RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...
November 3, 2023, 11:30 pm
How much gold should i own?
Most experts recommend limiting your gold investment to 10% or less of your overall portfolio. The rang...
November 3, 2023, 7:44 pm
Update: korro bio and frequency therapeutics announce closing of merger and private placement of $117 million
Korro will be focused on advancing a wholly owned portfolio of RNA editing programs Post-transaction ca...
November 3, 2023, 7:31 pm
Mufg trade of the week: going short usd/mxn, and short usd/sek
MUFG Research added 2 new trades to its TOTW portfolio. Short USD/MXN - (spot ref @ 17.400), Target @ 1...
November 3, 2023, 4:40 pm
Alliant energy: time to consider buying this blue-chip dividend stock
Utilities can be part of a portfolio geared toward reliable dividend growth. Thanks to its capital grow...
November 3, 2023, 4:31 pm
Korro bio and frequency therapeutics announce closing of merger and private placement of $117 million
Korro will be focused on advancing a wholly owned portfolio of RNA editing programs Post-transaction ca...
November 3, 2023, 4:19 pm
Ventas' (vtr) q3 ffo beat on shop noi growth, '23 view revised
Ventas's (VTR) Q3 earnings outshine estimates on better-than-anticipated revenues. The same-store cash NOI rises year over year on strong performance ...
November 3, 2023, 2:17 pm
Will spin-off plans help site centers (sitc) stock trend higher?
SITE Centers (SITC) under Fitch's "Rating Watch Positive" after it announces Convenience assets spin-off along with its Q3 results. A streamlined reta...
November 3, 2023, 1:32 pm
Is blackrock’s bitcoin etf just the beginning?
The financial world is vibrating with excitement after BlackRock, the world's largest asset manager, submitted a proposal for a Bitcoin exchange-trade...
November 3, 2023, 11:45 am